A possible association between suspected restrictive pattern as assessed by ordinary pulmonary function test and the metabolic syndrome

Chest

Volumn 134, Issue 4, 2008, Pages 712-718

  Nakajima, Kei ^a   Kubouchi, Yoichi ^b   Muneyuki, Toshitaka ^b   Ebata, Midori ^a   Eguchi, Satoko ^a   Munakata, Hiromi ^b  

^a JOSAI UNIVERSITY   (Japan)

^b Social Health Insurance OMIYA General Hospital   (Japan)

Author keywords

C reactive protein; Metabolic syndrome; Pulmonary function; Restrictive pattern

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ANALYZER; ARTICLE; CIGARETTE SMOKING; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INSULIN RESISTANCE; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; METABOLIC SYNDROME X; NORMAL HUMAN; PREDICTION; PRIORITY JOURNAL; SPIROMETRY; WAIST CIRCUMFERENCE;

EID: 54249113607     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-3003     Document Type: Article

References (33)

1. Engstrom G, Hedblad B, Nilsson P, et al. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med 2003; 253:574-581
2. Lazarus R, Sparrow D, Weiss ST. Impaired ventilatory function and elevated insulin levels in nondiabetic males: the Normative Aging Study. Eur Respir J 1998; 12:635-640
3. Lawlor DA, Ebrahim S, Smith GD. Associations of measures of lung function with insulin resistance and type 2 diabetes: findings from the British Women's Heart and Health Study. Diabetologia 2004; 47:195-203
4. Fimognari FL, Pasqualetti P, Moro L, et al. The association between metabolic syndrome and restrictive ventilatory dysfunction in older persons. J Gerontol A Biol Sci Med Sci 2007; 62:760-765
5. Ford ES, Mannino DM. Prospective association between lung function and the incidence of diabetes: findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Diabetes Care 2004; 27:2966-2970
6. Davis WA, Knuiman M, Kendall P, et al. Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 2004; 27:752-757
7. Yeh HC, Punjabi NM, Wang NY, et al. Vital capacity as a predictor of incident type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 2005; 28:1472-1479
8. Schnack C, Festa A, Schwarzmaier-D'Assié A, et al. Pulmonary dysfunction in type 1 diabetes in relation to metabolic long-term control and to incipient diabetic nephropathy. Nephron 1996; 74:395-400
9. Makkar P, Gandhi M, Agrawal RP, et al. Ventilatory pulmonary function tests in type 1 diabetes mellitus. J Assoc Physicians India 2000; 48:962-966
10. Boulbou MS, Gourgoulianis KI, Klisiaris VK, et al. Diabetes mellitus and lung function. Med Princ Pract 2003; 12:87-91
11. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med 2003; 114:758-762
12. Gan WQ, Man SF, Senthilselvan A, et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59:574-580
13. Engström G, Lind P, Hedblad B, et al. Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation 2002; 106:2555-2560
14. Fogarty AW, Jones S, Britton JR, et al. Systemic inflammation and decline in lung function in a general population: a prospective study. Thorax 2007; 62:515-520
15. Lin WY, Yao CA, Wang HC, et al. Impaired lung function is associated with obesity and metabolic syndrome in adults. Obesity 2006; 14:1654-1661
16. Malik S, Wong ND, Franklin S, et al. Cardiovascular disease in US patients with metabolic syndrome, diabetes, and elevated C-reactive protein. Diabetes Care 2005; 28:690-693
17. Ridker PM, Buring JE, Cook NR, et al. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003; 107:391-397
18. Ridker PM, Wilson PW, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004; 109:2818-2825
19. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26:948-968
20. Aaron SD, Dales RE, Cardinal P. How accurate is spirometry at predicting restrictive pulmonary impairment? Chest 1999; 115:869-873
21. Ochs-Balcom HM, Grant BJ, Muti P, et al. Pulmonary function and abdominal adiposity in the general population. Chest 2006; 129:853-862
22. Chen Y, Rennie D, Cormier YF, et al. Waist circumference is associated with pulmonary function in normal-weight, overweight, and obese subjects. Am J Clin Nutr 2007; 85:35-39
23. Greenfield JR, Samaras K, Jenkins AB, et al. Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences. Circulation 2004; 109:3022-3028
24. Kahn SE, Zinman B, Haffner SM, et al. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes 2006; 55:2357-2364
25. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112:2735-2752
26. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Available at: http://www.idf.org/webdata/docs/ Metabolic_syndrome_definition.pdf. Accessed July 29, 2008
27. Committee for the Diagnostic Criteria of Metabolic Syndrome. The definition and diagnostic criteria of metabolic syndrome. Nippon Naika Gakkai Zasshi 2005; 94:794-809
28. Japanese Respiratory Society. Reference values of spirogram and arterial blood gas levels in Japanese. Tokyo, Japan: Japanese Respiratory Society, 2001 [in Japanese]
29. Aggarwal AN, Agarwal R. The new ATS/ERS guidelines for assessing the spirometric severity of restrictive lung disease differ from previous standards. Respirology 2007; 12:759-762
30. Hardie JA, Buist AS, Vollmer WM, et al. Risk of overdiagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002; 20:1117-1122
31. Myers GL, Rifai N, Tracy RP, et al. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice; report from the laboratory science discussion group. Circulation 2004; 110:e545-e549
32. Tamura G, Aizawa H, Nagai A, et al. Common prediction equations of respiratory function tests from children to adults in Japan. Nihon Kokyuki Gakkai Zasshi 2007; 45:526-542
33. Pistelli F, Bottai M, Carrozzi L, et al. Reference equations for spirometry from a general population sample in central Italy. Respir Med 2007; 101:814-825